Evidence map›Paper›PMID 9989835›Full record

ArticleOncogene1999

Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes.

O Rey, M A Baluda, N H Park

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

O ReyUCLA School of Dentistry and Dental Research Institute, Los Angeles, California 90095-1668, USA.
M A Baluda
N H Park
University of California, Los Angeles · US

Funding

UCLA KING DREW RRCMOHP50DE010598 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BERTOLAMI, CHARLES N · 1995 to 2000
$1.0M
UCLA-DREW MINORITY HEALTH RESEARCH CENTERP20DE010598 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARCUS, MARVIN · 1992 to 1994
–
GENES FOR ORAL CARCINOGENESISR03DE011728 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PARK, NO-HEE · 1996 to 1997
–
NIDCR NIH HHS DE10598NIDCR NIH HHS DE11728
6 · The paper itself

Abstract

We have previously demonstrated that normal human oral keratinocytes immortalized by transfection with human papillomavirus type-16 Dna became tumorigenic after exposure to a chemical carcinogen. In an effort to detect differentially regulated genes associated with this transition from the immortal to the malignant phenotype, we employed representational differences analysis (a PCR-coupled subtractive hybridization technique). After analysing 50 colonies, 12 putative messages were identified. Northern analysis comparison using the identified cDNAs as probes was made between normal human oral keratinocyte, papillomavirus-immortalized human oral keratinocytes (HOK-16B), a neoplastic cell line derived from HOK-16B (HOK-16B-BaP-T) and the human oral cancer cell lines Hep-2, SCC-9 and Tu-177. We found that mRNAs encoding for cyclophilin A, c-myc binding protein 1, the heat shock protein 90alpha and one unknown transcript were up-regulated in the oral cancer cell lines analysed as well as in HOK-16B cells. We also detected a downregulation of the mRNAs encoding the skin-derived antileukoproteinase SKALP/elafin, the translationally regulated p23 protein and one unknown transcript. Whether these messages are associated to the neoplastic conversion of human keratinocytes remains to be determined.

Indexed as

Gene Expression Regulation, NeoplasticHumansKeratinocytesMouthPapillomaviridaeTumor Cells, Cultured

Identifiers

PMID9989835
OpenAlexW1998861687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.